HeimIDXX • NASDAQ
add
IDEXX Laboratories Inc
714,10 $
Eftir lokun(0,00%)0,00
714,10 $
Lokað: 5. des., 16:49:59 GMT-5 · USD · NASDAQ · Lagalegir fyrirvarar
Við síðustu lokun
717,47 $
Dagbil
710,51 $ - 722,71 $
Árabil
356,25 $ - 769,98 $
Markaðsvirði
57,02 ma. USD
Meðalmagn
636,71 þ.
V/H-hlutf.
77,53
A/V-hlutfall
-
Aðalkauphöll
NASDAQ
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | sep. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 1,11 ma. | 13,29% |
Rekstrarkostnaður | 328,51 m. | 12,45% |
Nettótekjur | 274,61 m. | 17,94% |
Hagnaðarhlutfall | 24,85 | 4,11% |
Hagnaður á hvern hlut | 3,40 | 21,43% |
EBITDA | 391,47 m. | 15,81% |
Virkt skatthlutfall | 20,35% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | sep. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 208,17 m. | -32,55% |
Heildareignir | 3,39 ma. | 1,07% |
Heildarskuldir | 1,83 ma. | 5,36% |
Eigið fé alls | 1,56 ma. | — |
Útistandandi hlutabréf | 79,85 m. | — |
Eiginfjárgengi | 36,76 | — |
Arðsemi eigna | 26,41% | — |
Ávöxtun eigin fjár | 33,04% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | sep. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 274,61 m. | 17,94% |
Handbært fé frá rekstri | 402,34 m. | 82,82% |
Reiðufé frá fjárfestingum | -44,87 m. | -63,95% |
Reiðufé frá fjármögnun | -313,31 m. | -7,67% |
Breyting á handbæru fé | 43,57 m. | 146,87% |
Frjálst peningaflæði | 226,67 m. | 32,11% |
Um
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. Wikipedia
Framkvæmdastjóri
Stofnsett
19. des. 1983
Höfuðstöðvar
Vefsvæði
Starfsfólk
11.000
